Leaders call on Congress to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA)

The purpose of the Pandemic and All-Hazards Preparedness Act is “to improve the Nation’s public health and medical preparedness and response capabilities for emergencies, whether deliberate, accidental, or natural.”

Photo by AZBio

Over 110 organizations representing the health innovation and public health community, including the Johns Hopkins Center for Health Security, the Biotechnology Innovation Organization (BIO), and AZBio sent a letter to Congress supporting the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) by the end of this year. Congress temporarily extended some PAHPA authorities in this year’s appropriations cycle, but those authorities will expire on December 31.

“Representing academia, industry, healthcare, and research, these groups recognize the unique opportunity for Congress to strengthen the nation’s health security programs now, as the country transitions to new leadership in 2025. This renewed call for passage follows several previous calls for reauthorization since PAHPA expired in September 2023.

Congress has a 17-year bipartisan history of improving the country’s preparedness for future national health security threats through PAHPA’s legislative framework. Reauthorization at this pivotal transition moment can help equip the incoming administration with the tools needed to respond quickly to health emergencies from day one.”  Source: Johns Hopkins Center for Health Security

PAHA’s Major Program Areas

  • Biomedical Advanced Research and Development Authority (BARDA) and Medical Countermeasures;
  • Emergency Support Function (ESF) #8: Public Health and Medical Response: Domestic Programs;
  • Emergency Support Function (ESF) #8: Public Health and Medical Response: International Programs;
  • Grants;
  • At-Risk Individuals;
  • National Health Security Strategy (NHSS);
  • Situational Awareness: Surveillance, Credentialing, and Telehealth; and
  • Education and Training

Read the full letter

Signatories, in alphabetical order:

  • 1Day Sooner
  • Acadian Companies
  • Adjuvant Capital, LP
  • AdvaMed
  • Aequor Inc.
  • American Academy of Pediatrics
  • American Ambulance Association
  • American Clinical Laboratory Association
  • American College of Emergency Physicians
  • American College of Physicians
  • American College of Surgeons
  • American Lung Association
  • American Medical Manufacturers Association (AMMA)
  • American Public Health Association
  • American Society for Microbiology
  • Antheia, Inc.
  • Arizona Bioindustry Association, Inc. (AZBio)
  • Association of American Medical Colleges
  • Association of Maternal & Child Health Programs
  • Association of Public Health Laboratories
  • Asthma and Allergy Foundation of America
  • ATCC
  • Atea Pharmaceuticals, Inc.
  • Bavarian Nordic
  • Big Cities Health Coalition
  • BIO
  • Biocom California
  • BioCT
  • BioForward Wisconsin
  • BioNJ
  • BioUtah
  • BluZoneBio LLC
  • Bugworks
  • California Life Sciences
  • Cencora (formerly AmerisourceBergen)
  • Civitas Networks for Health
  • Codagenix
  • Colorado BioScience Association
  • Council of State and Territorial Epidemiologists
  • Council of State Bioscience Associations
  • Dentec Safety Specialists
  • Elusys Therapeutics, Inc.
  • Emergent BioSolutions
  • Federation of American Hospitals
  • FluGen Inc.
  • Genentech, a member of the Roche Group
  • Georgetown University
  • Georgia Bio
  • Gerontological Society of America
  • Global Health Investment Corporation (GHIC)
  • Global Health Technologies Coalition
  • GSK
  • Hamilton Grace LLC
  • Harvard Kennedy School, Belfer Center for Science and International Affairs
  • Health Industry Distributors Association
  • Health Supply US
  • Healthcare Distribution Alliance
  • Healthcare Information and Management Systems Society (HIMSS)
  • Helix, Inc. 
  • High Alert Institute, Inc.
  • HIV Medicine Association
  • IAVI
  • Illinois Biotechnology Innovation Organization, iBIO
  • Indiana Life Sciences Association
  • Infectious Diseases Society of America
  • Institute for Progress
  • Johns Hopkins Center for Health Security
  • Life Science Tennessee
  • Life Sciences Pennsylvania
  • Maryland Tech Council
  • Mass General Brigham
  • Massachusetts Biotechnology Council (MassBio)
  • Maxter Healthcare Inc
  • Medical Alley
  • Medical Countermeasures Coalition
  • Michigan Biosciences Industry Association (MichBio)
  • Missouri Biotechnology Association
  • Montana BioScience Alliance
  • Mount Sinai Health System
  • NC Life Sciences Organization
  • Neuroene Therapeutics
  • New Mexico Biotechnology & Biomedical Association
  • New Orleans BioInnovation Center
  • NewYorkBIO
  • Ohio Life Sciences
  • Oregon Bioscience Association
  • Premier Inc.
  • Public Health Accreditation Board
  • READDI, Inc.
  • Recce Pharmaceuticals Ltd
  • Research!America
  • Roche Diagnostics
  • SAB Biotherapeutics, Inc.
  • Sanofi
  • Scbio
  • Scorpius Biomanufacturing
  • Shionogi Inc.
  • SIGA Technologies, Inc.
  • SoCalBio
  • Society for Public Health Education
  • South Dakota Biotech Association
  • SPOC Proteomics, Inc.
  • Texas Healthcare & Bioscience Institute
  • Tonix Pharmaceuticals, Inc
  • Trinity Health
  • TrippBio, Inc.
  • Trust for America’s Health
  • United Safety Technology Inc.
  • University of Nebraska System
  • Valneva USA
  • Vaxxas Inc
  • VIDA 
Posted in Advocacy and Regulations, AZBio News.